Global Ophthalmics Partnering Analysis 2010-2015 - Deal Trends, Players and Financials

Nov 16, 2015, 14:10 ET from Research and Markets

DUBLIN, Nov. 16, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Global Ophthalmics Partnering 2010-2015: Deal trends, players and financials" report to their offering.

The Global Ophthalmics Partnering 2010-2015 report provides an understanding and access to the ophthalmics partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter ophthalmics partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors ophthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest ophthalmics agreements announced in the healthcare sector.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

Report scope

Global Ophthalmics Partnering 2010-2015 includes:

  • Trends in ophthalmics dealmaking in the biopharma industry since 2010
  • Analysis of ophthalmics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to around 400 ophthalmics deal records
  • The leading ophthalmics deals by value since 2010

In Global Ophthalmics Partnering 2010-2015, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in ophthalmics dealmaking

Chapter 3 - Leading ophthalmics deals

Chapter 4 - Big pharma ophthalmics deals

Chapter 5 - Big biotech ophthalmics deals

Chapter 6 - Ophthalmics partnering contracts directory

Chapter 7 - Ophthalmics dealmaking by therapeutic target

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets